Real-world data demonstrate that nirsevimab and maternal vaccination protect infants against severe RSV outcomes.

The age-adjusted suicide rate increased from 2014 to 2017 and then did not change significantly from 2017 through 2024.

Data presented at USCHA 2026 demonstrate that culturally-responsive campaigns significantly improve HIV PrEP awareness.

MenB coverage was improved but still suboptimal among individuals aged 10 to 25 years who had high-risk conditions, with an overall initiation rate of 39%. Patients with asplenia were most likely to ...

A large-scale testing initiative identified patients in the Puerto Rican correctional system with positive results for HIV ...

Integrating community pharmacies into the HIV prevention landscape offers accessible, disease-agnostic entry points for PrEP ...

A mobile retail pharmacy and clinic model in Connecticut improves HIV care and substance use treatment for vulnerable ...

Disparities in pre-exposure prophylaxis access and routine screening continue to hinder national efforts to prevent and treat ...

Updated BNT162b2 KP.2 vaccination reduces COVID-19 hospitalizations and ED visits in immunocompetent adults regardless of risk status.

Dr Marissa Robinson discusses structural barriers to HIV PrEP access and strategies to enhance health equity in care delivery ...

Previous STI history is linked to increased current PrEP use, though uptake disparities remain across patient demographic ...

New legislative efforts seek to address housing instability and prevent discrimination against aging people living with HIV ...